IDEXX Laboratories, Inc. (ETR:IX1)
Germany · Delayed Price · Currency is EUR 615.60
-3.60 (-0.58%)
At close: Nov 7, 2025
IDEXX Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 4,167 | 3,898 | 3,661 | 3,367 | 3,215 | 2,707 | Upgrade | |
Revenue Growth (YoY) | 8.39% | 6.46% | 8.72% | 4.73% | 18.80% | 12.45% | Upgrade |
Cost of Revenue | 1,595 | 1,519 | 1,471 | 1,363 | 1,326 | 1,136 | Upgrade |
Gross Profit | 2,572 | 2,379 | 2,190 | 2,004 | 1,889 | 1,571 | Upgrade |
Selling, General & Admin | 1,033 | 969.3 | 901.89 | 850.75 | 796.4 | 735.27 | Upgrade |
Research & Development | 242.1 | 219.79 | 190.95 | 254.82 | 161.01 | 141.25 | Upgrade |
Operating Expenses | 1,275 | 1,189 | 1,093 | 1,106 | 957.4 | 876.52 | Upgrade |
Operating Income | 1,297 | 1,190 | 1,097 | 898.77 | 932.03 | 694.52 | Upgrade |
Interest Expense | -37.14 | -31.21 | -41.58 | -39.86 | -29.81 | -33.13 | Upgrade |
Interest & Investment Income | 4.62 | 12.7 | 5.63 | 1.07 | 0.43 | 0.59 | Upgrade |
EBT Excluding Unusual Items | 1,265 | 1,171 | 1,061 | 859.97 | 902.65 | 661.99 | Upgrade |
Legal Settlements | 9 | -61.5 | - | - | - | - | Upgrade |
Pretax Income | 1,274 | 1,110 | 1,061 | 859.97 | 902.65 | 661.99 | Upgrade |
Income Tax Expense | 246.17 | 221.96 | 216.13 | 180.88 | 157.81 | 79.85 | Upgrade |
Earnings From Continuing Operations | 1,027 | 887.87 | 845.04 | 679.09 | 744.84 | 582.13 | Upgrade |
Minority Interest in Earnings | - | - | - | - | 0 | -0.36 | Upgrade |
Net Income | 1,027 | 887.87 | 845.04 | 679.09 | 744.85 | 581.78 | Upgrade |
Net Income to Common | 1,027 | 887.87 | 845.04 | 679.09 | 744.85 | 581.78 | Upgrade |
Net Income Growth | 18.61% | 5.07% | 24.44% | -8.83% | 28.03% | 36.02% | Upgrade |
Shares Outstanding (Basic) | 81 | 82 | 83 | 84 | 85 | 85 | Upgrade |
Shares Outstanding (Diluted) | 82 | 83 | 84 | 85 | 87 | 87 | Upgrade |
Shares Change (YoY) | -2.45% | -0.87% | -0.73% | -2.28% | -0.17% | -0.94% | Upgrade |
EPS (Basic) | 12.70 | 10.77 | 10.17 | 8.12 | 8.74 | 6.82 | Upgrade |
EPS (Diluted) | 12.60 | 10.67 | 10.06 | 8.03 | 8.60 | 6.71 | Upgrade |
EPS Growth | 21.65% | 6.06% | 25.28% | -6.63% | 28.17% | 37.22% | Upgrade |
Free Cash Flow | 963.57 | 808.08 | 772.88 | 394.15 | 636 | 541.11 | Upgrade |
Free Cash Flow Per Share | 11.82 | 9.71 | 9.20 | 4.66 | 7.35 | 6.24 | Upgrade |
Gross Margin | 61.72% | 61.04% | 59.82% | 59.52% | 58.76% | 58.04% | Upgrade |
Operating Margin | 31.13% | 30.53% | 29.97% | 26.69% | 28.99% | 25.66% | Upgrade |
Profit Margin | 24.65% | 22.78% | 23.08% | 20.17% | 23.16% | 21.49% | Upgrade |
Free Cash Flow Margin | 23.12% | 20.73% | 21.11% | 11.71% | 19.78% | 19.99% | Upgrade |
EBITDA | 1,437 | 1,320 | 1,212 | 1,011 | 1,037 | 790.52 | Upgrade |
EBITDA Margin | 34.49% | 33.86% | 33.11% | 30.01% | 32.24% | 29.21% | Upgrade |
D&A For EBITDA | 140.17 | 129.94 | 114.91 | 111.9 | 104.6 | 96 | Upgrade |
EBIT | 1,297 | 1,190 | 1,097 | 898.77 | 932.03 | 694.52 | Upgrade |
EBIT Margin | 31.13% | 30.53% | 29.97% | 26.69% | 28.99% | 25.66% | Upgrade |
Effective Tax Rate | 19.33% | 20.00% | 20.37% | 21.03% | 17.48% | 12.06% | Upgrade |
Revenue as Reported | 4,167 | 3,898 | 3,661 | 3,367 | 3,215 | 2,707 | Upgrade |
Advertising Expenses | - | 3.4 | 4.2 | 5 | 3.3 | 1.4 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.